PHGE.U / BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder t - Insider Trading and Ownership Report - SEC Form 3, 4, 5

BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder t
US ˙ AMEX
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

Insideraktier12.988.695 shares
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

N/A

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

N/A

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder t insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i PHGE.U / BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder t. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2023-05-22 Oron Assaf 3.192 0,2731 319 2,7310 872 289 0.6879 -652 -74,81
2023-05-19 Oron Assaf 6.521 0,2809 652 2,8090 1.832
2023-05-18 Oron Assaf 1.201 0,2727 120 2,7270 328
2023-02-27 OrbiMed Israel BioFund GP Limited Partnership 348.000 0,2450 34.800 2,4500 85.260
2021-07-28 SEKHRI PAUL J 12.500 4,0000 1.250 40,0000 50.000
2021-07-28 Sullivan Lynne Marie 12.500 4,0000 1.250 40,0000 50.000
2021-07-28 Solomon Jonathan Eitan 25.000 4,0000 2.500 40,0000 100.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PHGE.U / BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder t Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i PHGE.U / BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder t. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2024-05-15 OrbiMed Israel BioFund GP Limited Partnership 24.344 0,3812 2.434 3,8120 9.280 100 0.1374 -8.945 -96,40
2023-11-29 Oron Assaf 2.056 0,3400 206 3,4000 699
2023-11-29 Oron Assaf 3.414 0,3500 341 3,5000 1.195
2023-11-29 Oron Assaf 5.444 0,4000 544 4,0000 2.178
2022-11-04 Ugwumba Chidozie 1.501 0,3780 150 3,7800 567
2022-11-03 Ugwumba Chidozie 2.000 0,3660 200 3,6600 732
2022-11-02 Ugwumba Chidozie 2.416 0,3590 242 3,5900 867
2022-11-01 Ugwumba Chidozie 1.300 0,3640 130 3,6400 473
2022-10-31 Ugwumba Chidozie 3.300 0,3710 330 3,7100 1.224

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PHGE.U / BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder t Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2025-04-21 2025-04-14 4/A Bassan Merav PHGE Common Stock A - Award D 79.597 79.597
2025-04-21 2025-04-14 4/A Solomon Jonathan Eitan PHGE Common Stock A - Award D 126.748 126.748
2025-04-21 2025-04-14 4/A Wolfson Marina PHGE Common Stock A - Award D 68.545 68.545
2025-04-18 2025-04-14 4 Solomon Jonathan Eitan PHGE Common Stock A - Award D 126.748 126.748
2025-04-18 2025-04-14 4 Bassan Merav PHGE Common Stock A - Award D 79.597 79.597
2025-04-18 2025-04-14 4 Wolfson Marina PHGE Common Stock A - Award D 68.545 68.545
2025-03-04 2024-07-15 5 Cystic Fibrosis Foundation PHGE Common Stock, par value $0.0001 per share C - Conversion D 854.700 1.787.758
2025-03-03 2025-02-27 4 Flynn James E Through Deerfield Healthcare Innovations Fund II, L.P. PHGE Common Stock M - Exercise I 0,9306 353.249 329 1.247.054
2025-03-03 2025-02-27 4 Flynn James E Through Deerfield Private Design Fund V, L.P. PHGE Common Stock M - Exercise I 0,9306 353.249 329 1.247.054
2024-09-18 2024-09-16 4 Bassan Merav PHGE Common Stock A - Award D 31.749 31.749
2024-09-18 2024-09-16 4 Oron Assaf PHGE Common Stock A - Award D 25.804 25.804
2024-09-18 2024-09-16 4 Solomon Jonathan Eitan PHGE Common Stock A - Award D 50.556 53.056
2024-07-17 2024-07-15 4 Flynn James E Through Deerfield Private Design Fund V, L.P. PHGE Common Stock M - Exercise I 5.883.000 8.938.049
2024-07-17 2024-07-15 4 Flynn James E Through Deerfield Healthcare Innovations Fund II, L.P. PHGE Common Stock M - Exercise I 5.883.000 8.938.049
2024-05-20 2024-05-15 4 OrbiMed Israel BioFund GP Limited Partnership See footnotes PHGE Common Stock S - Sale I 0,3812 -24.344 -9 13.773.653
2024-05-20 2024-05-15 4 OrbiMed Israel BioFund GP Limited Partnership See footnotes PHGE Common Stock X - Other I 0,2440 9.280.408 2.264 13.797.997
2024-05-17 2024-05-15 4 Cystic Fibrosis Foundation PHGE Common Stock, par value $0.0001 per share X - Other D 0,0010 4.778.265 5 9.330.580
2024-03-26 3 Cystic Fibrosis Foundation PHGE Common Stock, par value $0.0001 per share D 4.552.315
2024-03-19 2024-03-15 4 Flynn James E Through Deerfield Healthcare Innovations Fund II, L.P. PHGE Common Stock A - Award I 3.055.049 3.055.049
2024-03-19 2024-03-15 4 Flynn James E Through Deerfield Private Design Fund V, L.P. PHGE Common Stock A - Award I 3.055.049 3.055.049
2023-12-01 2023-11-29 4 Oron Assaf PHGE Common Stock S - Sale D 0,3400 -2.056 -1 0
2023-12-01 2023-11-29 4 Oron Assaf PHGE Common Stock S - Sale D 0,3500 -3.414 -1 2.056
2023-12-01 2023-11-29 4 Oron Assaf PHGE Common Stock S - Sale D 0,4000 -5.444 -2 5.470
2023-05-24 2023-05-22 4 Oron Assaf PHGE Common Stock P - Purchase D 0,2731 3.192 1 10.914
2023-05-22 2023-05-19 4 Oron Assaf PHGE Common Stock P - Purchase D 0,2809 6.521 2 7.722
2023-05-22 2023-05-18 4 Oron Assaf PHGE Common Stock P - Purchase D 0,2727 1.201 0 1.201
2023-03-17 2023-02-27 4 OrbiMed Israel BioFund GP Limited Partnership See Footnotes PHGE Common Stock P - Purchase I 0,2450 348.000 85 3.161.489
2022-11-14 2022-11-04 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3780 -1.501 -1 2.997.025
2022-11-14 2022-11-03 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3660 -2.000 -1 2.998.526
2022-11-14 2022-11-02 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3590 -2.416 -1 3.000.526
2022-11-14 2022-11-01 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3640 -1.300 -0 3.002.942
2022-11-14 2022-10-31 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3710 -3.300 -1 3.004.242
2022-11-14 2022-10-28 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3560 -1.526 -1 3.007.542
2022-11-14 2022-10-27 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3640 -1.505 -1 3.009.068
2022-11-14 2022-10-26 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3460 -12.500 -4 3.010.573
2022-11-14 2022-10-25 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3650 -3.072 -1 3.023.073
2022-11-14 2022-10-24 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3490 -5.900 -2 3.026.145
2022-11-14 2022-10-21 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3700 -5.400 -2 3.032.045
2022-11-14 2022-10-20 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3740 -6.636 -2 3.037.445
2022-11-14 2022-10-19 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3670 -4.501 -2 3.044.081
2022-11-14 2022-10-18 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3460 -15.300 -5 3.048.582
2022-11-14 2022-10-17 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3350 -8.098 -3 3.063.882
2022-11-14 2022-10-14 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3310 -3.420 -1 3.071.980
2022-11-14 2022-10-13 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3300 -11.314 -4 3.075.400
2022-11-14 2022-10-12 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3330 -9.700 -3 3.086.714
2022-11-14 2022-10-11 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3320 -5.988 -2 3.096.414
2022-11-14 2022-10-10 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3260 -10.043 -3 3.102.402
2022-11-14 2022-10-07 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3580 -24.708 -9 3.112.445
2022-11-14 2022-10-06 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,4440 -25.098 -11 3.137.153
2022-11-14 2022-10-05 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,4350 -46.785 -20 3.162.251
2022-11-14 2022-10-04 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3440 -19.200 -7 3.209.036
2022-11-14 2022-10-03 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3300 -15.022 -5 3.228.236
2022-11-14 2022-09-30 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3560 -8.662 -3 3.243.258
2022-11-14 2022-09-29 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3490 -3.300 -1 3.251.920
2022-11-14 2022-09-28 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3330 -15.649 -5 3.255.220
2022-11-14 2022-09-27 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3310 -4.866 -2 3.270.869
2022-11-14 2022-09-26 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3550 -17.528 -6 3.275.735
2022-11-14 2022-09-23 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,3740 -5.306 -2 3.293.263
2022-11-14 2022-09-22 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,4130 -17.388 -7 3.298.569
2022-11-14 2022-09-21 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,4270 -5.574 -2 3.315.957
2022-11-14 2022-09-20 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,4510 -10.626 -5 3.321.531
2022-11-14 2022-09-19 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,4850 -13.870 -7 3.332.157
2022-11-14 2022-09-16 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,5130 -3.200 -2 3.346.027
2022-11-14 2022-09-15 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,5310 -3.900 -2 3.349.227
2022-11-14 2022-09-14 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,5230 -2.301 -1 3.353.127
2022-11-14 2022-09-13 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,5250 -2.201 -1 3.335.428
2022-11-14 2022-09-12 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,5410 -1.700 -1 3.357.629
2022-11-14 2022-09-09 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,5180 -13.219 -7 3.359.329
2022-11-14 2022-09-08 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,5220 -4.592 -2 3.372.548
2022-11-14 2022-09-07 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,5280 -8.846 -5 3.377.140
2022-11-14 2022-09-06 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,5450 -6.403 -3 3.385.986
2022-11-14 2022-09-02 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,5460 -2.001 -1 3.392.389
2022-11-14 2022-09-01 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,5460 -8.297 -5 3.394.390
2022-11-14 2022-08-31 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,5490 -4.540 -2 3.402.687
2022-11-14 2022-08-30 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,5660 -13.487 -8 3.407.227
2022-11-14 2022-08-29 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,5710 -11.533 -7 3.420.714
2022-11-14 2022-08-26 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,6160 -60.628 -37 3.432.247
2022-11-14 2022-08-25 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,7180 -26.945 -19 3.492.875
2022-11-14 2022-08-24 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,6520 -8.665 -6 3.519.820
2022-11-14 2022-08-23 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,6380 -5.900 -4 3.528.485
2022-11-14 2022-08-22 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,6570 -5.000 -3 3.534.385
2022-11-14 2022-08-19 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,6390 -14.600 -9 3.539.385
2022-11-14 2022-08-18 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,6830 -7.764 -5 3.553.985
2022-11-14 2022-08-17 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,6880 -21.335 -15 3.561.749
2022-11-14 2022-08-16 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,7290 -8.563 -6 3.583.084
2022-11-14 2022-08-15 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,7470 -7.200 -5 3.591.647
2022-11-14 2022-08-12 4 Ugwumba Chidozie By Symbiosis, LLC PHGE Common Stock S - Sale I 0,7340 -11.406 -8 3.598.847
2022-11-14 2022-08-11 4 Ugwumba Chidozie By Symbiosis, LLC PHGE Common Stock S - Sale I 0,7440 -9.824 -7 3.610.253
2022-11-14 2022-08-10 4 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock S - Sale I 0,7400 -17.769 -13 3.620.077
2022-03-31 2022-03-29 4 GROSSMAN JONAS PHGE Common Stock Options - Right to Buy A - Award D 1,41 20.500 20.500
2022-03-31 2022-03-29 4 Sullivan Lynne Marie PHGE Common Stock Options - Right to Buy A - Award D 1,41 20.500 20.500
2022-03-31 2022-03-29 4 Amusa Gbolahan PHGE Common Stock Options - Right to Buy A - Award D 1,41 20.500 20.500
2022-03-31 2022-03-29 4 Greig Russell PHGE Common Stock Options - Right to Buy A - Award D 1,41 41.000 41.000
2022-03-31 2022-03-29 4 Wolfson Marina PHGE Common Stock Options - Right to Buy A - Award D 1,41 50.000 50.000
2022-03-31 2022-03-29 4 Solomon Jonathan Eitan PHGE Common Stock Options - Right to Buy A - Award D 1,41 205.000 205.000
2022-03-31 2022-03-29 4 Bassan Merav PHGE Common Stock Options - Right to Buy A - Award D 1,41 100.000 100.000
2022-03-31 2022-03-29 4 Moses Alan Charles PHGE Common Stock Options - Right to Buy A - Award D 1,41 20.500 20.500
2022-02-14 2021-12-31 4 Walton Thomas Layton By SymBiosis, LLC PHGE Warrants to purchase Common Stock J - Other I 5,00 -1.875.000 0
2022-02-14 2021-12-31 4 Walton Thomas Layton By SymBiosis, LLC PHGE Common Stock, $0.0001 par value J - Other I -3.637.846 0
2022-02-14 3 Ugwumba Chidozie By SymBiosis, LLC PHGE Common Stock I 3.637.846
2021-08-17 2021-07-26 4/A GROSSMAN JONAS PHGE Common Stock, par value $0.0001 P - Purchase D 37.500 372.717
2021-08-17 2020-07-26 4/A GROSSMAN JONAS PHGE Warrants to purchase Common Stock P - Purchase D 5,00 28.125 28.125
2021-08-09 3 Walton Thomas Layton By SymBiosis, LLC PHGE Common Stock, $0.0001 par value I 3.637.846
2021-07-30 2021-07-28 4 OrbiMed Israel BioFund GP Limited Partnership See Footnotes PHGE Warrants (Right to Buy) P - Purchase I 5,00 375.000 375.000
2021-07-30 2021-07-28 4 OrbiMed Israel BioFund GP Limited Partnership See Footnotes PHGE Common Stock, $0.0001 par value P - Purchase I 500.000 2.813.489
2021-07-30 2021-07-28 4 Wolfson Marina PHGE Common Stock Warrant P - Purchase D 5,00 2.813 2.813
2021-07-30 2021-07-28 4 Wolfson Marina PHGE Common Stock P - Purchase D 4,0000 3.750 15 3.750
2021-07-30 2021-07-28 4 Sullivan Lynne Marie PHGE Common Stock Warrant P - Purchase D 5,00 9.375 9.375
2021-07-30 2021-07-28 4 Sullivan Lynne Marie PHGE Common Stock P - Purchase D 4,0000 12.500 50 12.500
2021-07-30 2021-07-28 4 Solomon Jonathan Eitan PHGE Common Stock Warrant P - Purchase D 5,00 18.750 18.750
2021-07-30 2021-07-28 4 Solomon Jonathan Eitan PHGE Common Stock P - Purchase D 4,0000 25.000 100 25.000
2021-07-30 2021-07-28 4 SEKHRI PAUL J PHGE Common Stock Warrant P - Purchase D 5,00 9.375 9.375
2021-07-30 2021-07-28 4 SEKHRI PAUL J PHGE Common Stock P - Purchase D 4,0000 12.500 50 12.500
2021-07-30 2021-07-28 4 Greig Russell PHGE Common Stock Warrant P - Purchase I 5,00 2.813 2.813
2021-07-30 2021-07-28 4 Greig Russell PHGE Common Stock P - Purchase I 4,0000 3.750 15 3.750
2021-07-30 2021-07-28 4 Moses Alan Charles PHGE Common Stock Warrant P - Purchase D 5,00 3.750 3.750
2021-07-30 2021-07-28 4 Moses Alan Charles PHGE Common Stock P - Purchase D 4,0000 5.000 20 5.000
2021-07-28 2021-07-26 4 GROSSMAN JONAS PHGE Warrants to purchase Common Stock P - Purchase D 5,00 28.125 28.125
2021-07-28 2021-07-26 4 GROSSMAN JONAS PHGE Common Stock, par value $0.0001 P - Purchase D 37.500 372.217
2021-07-28 2021-07-26 4 Amusa Gbolahan PHGE Warrants to purchase Common Stock P - Purchase D 5,00 18.750 18.750
2021-07-28 2021-07-26 4 Amusa Gbolahan PHGE Common Stock, par value $0.0001 P - Purchase D 25.000 262.871
2021-04-01 2021-03-30 4 Puttagunta Sailaja PHGE Common Stock Options - Right to Buy A - Award D 7,02 71.250 71.250
2021-04-01 2021-03-30 4 Greig Russell PHGE Common Stock Options - Right to Buy A - Award D 7,02 30.400 30.400
2021-04-01 2021-03-30 4 SEKHRI PAUL J PHGE Common Stock Options - Right to Buy A - Award D 7,02 15.200 15.200
2021-04-01 2021-03-30 4 Oron Assaf PHGE Common Stock Options - Right to Buy A - Award D 7,02 33.250 33.250
2021-04-01 2021-03-30 4 Moses Alan Charles PHGE Common Stock Options - Right to Buy A - Award D 7,02 15.200 15.200
2021-04-01 2021-03-30 4 Bassan Merav PHGE Common Stock Options - Right to Buy A - Award D 7,02 47.500 47.500
2021-04-01 2021-03-30 4 Wolfson Marina PHGE Common Stock Options - Right to Buy A - Award D 7,02 33.250 33.250
2021-04-01 2021-03-30 4 Sullivan Lynne Marie PHGE Common Stock Options - Right to Buy A - Award D 7,02 15.200 15.200
2021-04-01 2021-03-30 4 Solomon Jonathan Eitan PHGE Common Stock Options - Right to Buy A - Award D 7,02 152.000 152.000
2021-04-01 2021-03-30 4 GROSSMAN JONAS PHGE Common Stock Options - Right to Buy A - Award D 7,02 15.200 15.200
2021-04-01 2021-03-30 4 Amusa Gbolahan PHGE Common Stock Options - Right to Buy A - Award D 7,02 15.200 15.200
2020-10-05 2020-10-02 4 SEKHRI PAUL J PHGE Common Stock Options - Right to Buy A - Award D 6,44 16.000 16.000
2020-10-05 2020-10-02 4 Moses Alan Charles PHGE Common Stock Options - Right to Buy A - Award D 6,44 16.000 16.000
2020-07-27 2020-07-13 4 Amusa Gbolahan PHGE Warrants to purchase Common Stock J - Other D 11,50 276.190 276.190
2020-07-27 2020-07-13 4 Amusa Gbolahan PHGE Common Stock, par value $0.0001 J - Other D 95.148 237.871
2020-07-22 2020-07-13 4 PROPPER KERRY By Mountain Wood, LLC PHGE Warrants to purchase Common Stock J - Other I 11,50 -2.900.000 0
2020-07-22 2020-07-13 4 PROPPER KERRY PHGE Warrants to purchase Common Stock J - Other D 11,50 631.786 631.786
2020-07-22 2020-07-13 4 PROPPER KERRY By Mountain Wood, LLC PHGE Common Stock, par value $0.0001 J - Other I -999.058 0
2020-07-22 2020-07-13 4 PROPPER KERRY PHGE Common Stock, par value $0.0001 J - Other D 217.652 260.771
2020-07-22 2020-07-13 4 GROSSMAN JONAS PHGE Warrants to purchase Common Stock J - Other D 11,50 666.310 716.439
2020-07-22 2020-07-13 4 GROSSMAN JONAS PHGE Common Stock, par value $0.0001 J - Other D 229.545 335.217
2020-07-22 2020-06-18 4 GROSSMAN JONAS By Ravenna LLC PHGE Common Stock, par value $0.0001 J - Other I -45.275 0
2020-06-12 2020-06-10 4 PROPPER KERRY By Mountain Wood, LLC PHGE Common Stock, par value $0.0001 J - Other I 999.058 999.058
2020-06-12 2020-06-10 4 PROPPER KERRY PHGE Common Stock, par value $0.0001 J - Other D 43.119 43.119
2020-06-12 2020-06-10 4 Amusa Gbolahan PHGE Common Stock, par value $0.0001 J - Other D 142.723 142.723
2020-06-12 2020-06-10 4 GROSSMAN JONAS By Ravenna LLC PHGE Common Stock, par value $0.0001 J - Other I 42.275 45.275
2020-06-12 2020-06-10 4 GROSSMAN JONAS By Chardan Investments, LLC PHGE Common Stock, par value $0.0001 J - Other I -1.707.500 0
2020-06-12 2020-06-10 4 GROSSMAN JONAS PHGE Common Stock, par value $0.0001 J - Other D 99.172 105.672
2020-03-27 2020-03-25 4 Solomon Jonathan Eitan PHGE Common Stock Options - Right to Buy A - Award D 6,21 144.000 144.000
2020-03-27 2020-03-25 4 GROSSMAN JONAS PHGE Common Stock Options - Right to Buy A - Award D 6,21 16.000 16.000
2020-03-27 2020-03-25 4 Chimovits Erez PHGE Common Stock Options - Right to Buy A - Award D 6,21 16.000 16.000
2020-03-27 2020-03-25 4 Amusa Gbolahan PHGE Common Stock Options - Right to Buy A - Award D 6,21 16.000 16.000
2020-03-27 2020-03-25 4 Oron Assaf PHGE Common Stock Options - Right to Buy A - Award D 6,21 31.500 31.500
2020-03-27 2020-03-25 4 Sullivan Lynne Marie PHGE Common Stock Options - Right to Buy A - Award D 6,21 16.000 16.000
2020-03-27 2020-03-25 4 Breski Yaron PHGE Common Stock Options - Right to Buy A - Award D 6,21 16.000 16.000
2020-03-27 2020-03-25 4 Wolfson Marina PHGE Common Stock Options - Right to Buy A - Award D 6,21 36.000 36.000
2020-03-27 2020-03-25 4 Puttagunta Sailaja PHGE Common Stock Options - Right to Buy A - Award I 6,21 67.500 67.500
2020-03-27 2020-03-25 4 Greig Russell PHGE Common Stock Options - Right to Buy A - Award D 6,21 32.000 32.000
2019-12-30 2019-12-20 4 GROSSMAN JONAS PHGE Warrants J - Other I 11,50 -2.900.000 0
2019-12-20 2019-12-19 4 Chimovits Erez See Footnotes PHGE Common Stock, $0.001 par value P - Purchase I 8,9000 3.500 31 2.313.489
2019-12-20 2019-12-18 4 Chimovits Erez See Footnotes PHGE Common Stock, $0.001 par value P - Purchase I 8,9300 500 4 2.309.989
2019-12-20 2019-12-19 4 OrbiMed Israel BioFund GP Limited Partnership See Footnotes PHGE Common Stock, $0.001 par value P - Purchase I 8,9000 3.500 31 2.313.489
2019-12-20 2019-12-18 4 OrbiMed Israel BioFund GP Limited Partnership See Footnotes PHGE Common Stock, $0.001 par value P - Purchase I 8,9300 500 4 2.309.989
2019-12-12 2019-12-11 4 OrbiMed Israel BioFund GP Limited Partnership See Footnotes PHGE Common Stock, $0.001 par value P - Purchase I 8,9200 5.400 48 2.309.489
2019-12-12 2019-12-10 4 OrbiMed Israel BioFund GP Limited Partnership See Footnotes PHGE Common Stock, $0.001 par value P - Purchase I 8,7500 3.400 30 2.304.089
2019-12-12 2019-12-11 4 Chimovits Erez See Footnotes PHGE Common Stock, $0.001 par value P - Purchase I 8,9200 5.400 48 2.309.489
2019-12-12 2019-12-10 4 Chimovits Erez See Footnotes PHGE Common Stock, $0.001 par value P - Purchase I 8,7500 3.400 30 2.304.089
2019-12-09 2019-12-09 4 OrbiMed Israel BioFund GP Limited Partnership See Footnotes PHGE Common Stock, $0.001 par value P - Purchase I 8,6800 6.000 52 2.300.689
2019-12-09 2019-12-06 4 OrbiMed Israel BioFund GP Limited Partnership See Footnotes PHGE Common Stock, $0.001 par value P - Purchase I 8,0000 800 6 2.294.689
2019-12-09 2019-12-05 4 OrbiMed Israel BioFund GP Limited Partnership See Footnotes PHGE Common Stock, $0.001 par value P - Purchase I 7,9900 3.400 27 2.293.889
2019-12-09 2019-12-09 4 Chimovits Erez See Footnotes PHGE Common Stock, $0.001 par value P - Purchase I 8,6800 6.000 52 2.300.689
2019-12-09 2019-12-06 4 Chimovits Erez See Footnotes PHGE Common Stock, $0.001 par value P - Purchase I 8,0000 800 6 2.294.689
2019-12-09 2019-12-05 4 Chimovits Erez See Footnotes PHGE Common Stock, $0.001 par value P - Purchase I 7,9900 3.400 27 2.293.889
2019-11-20 2019-11-20 4 GROSSMAN JONAS PHGE Common Stock, par value $0.0001 P - Purchase D 8,0040 1.400 11 6.500
2019-11-20 2019-11-19 4 GROSSMAN JONAS PHGE Common Stock, par value $0.0001 P - Purchase D 7,5730 4.100 31 5.100
2019-11-20 2019-11-18 4 GROSSMAN JONAS PHGE Warrants P - Purchase D 11,50 0,5990 50.129 30 50.129
2019-11-20 2019-11-18 4 GROSSMAN JONAS PHGE Common Stock, par value $0.0001 P - Purchase D 6,9890 1.000 7 1.000
2019-11-07 3 Chimovits Erez See Footnotes PHGE Common Stock I 4.580.980
2019-11-07 3 Chimovits Erez See Footnotes PHGE Common Stock I 4.580.980
2019-11-07 3 Chimovits Erez See Footnotes PHGE Common Stock I 4.580.980
2019-11-07 3 OrbiMed Israel GP Ltd. See Footnotes PHGE Common Stock I 4.580.980
2019-11-07 3 OrbiMed Israel GP Ltd. See Footnotes PHGE Common Stock I 4.580.980
2019-11-07 3 OrbiMed Israel GP Ltd. See Footnotes PHGE Common Stock I 4.580.980
2019-11-07 3 OrbiMed Israel GP Ltd. See Footnotes PHGE Common Stock I 4.580.980
2019-11-05 3 Takeda Ventures, Inc. PHGE Common Stock I 4.941.870
2019-11-05 3 Takeda Ventures, Inc. PHGE Common Stock I 4.941.870
2019-11-05 3 Takeda Ventures, Inc. PHGE Common Stock I 4.941.870
2019-11-05 3 Takeda Ventures, Inc. PHGE Common Stock I 4.941.870
2019-09-19 3 MMCAP International Inc. SPC CHAC Common Stock D 3.400.000
2019-09-19 3 MMCAP International Inc. SPC CHAC Common Stock D 3.400.000
2019-09-19 3 MMCAP International Inc. SPC CHAC Common Stock D 3.400.000
2018-12-21 3 Gnedy Elliot CHAC Common Stock, par value $0.0001 D 15.000
2018-12-21 3 Gnedy Elliot CHAC Common Stock, par value $0.0001 D 15.000
2018-12-21 3 Gnedy Elliot CHAC Common Stock, par value $0.0001 D 15.000
2018-12-19 2018-12-18 4 GROSSMAN JONAS CHAC Warrants P - Purchase I 11,50 0,4000 2.900.000 1.160 2.900.000
2018-12-14 3 Kusseluk Eric CHAC Common Stock, par value $0.0001 D 15.000
2018-12-14 3 Kusseluk Eric CHAC Common Stock, par value $0.0001 D 15.000
2018-12-14 3 Kusseluk Eric CHAC Common Stock, par value $0.0001 D 15.000
2018-12-14 3 GROSSMAN JONAS CHAC Common Stock, par value $0.0001 I 3.940.000
2018-12-14 3 GROSSMAN JONAS CHAC Common Stock, par value $0.0001 I 3.940.000
2018-12-14 3 GROSSMAN JONAS CHAC Common Stock, par value $0.0001 I 3.940.000
2018-12-14 3 Rossen Matthew CHAC Common Stock, par value $0.0001 D 15.000
2018-12-14 3 Rossen Matthew CHAC Common Stock, par value $0.0001 D 15.000
2018-12-14 3 Rossen Matthew CHAC Common Stock, par value $0.0001 D 15.000
2018-12-14 3 RICE YEHUDA MICHAEL CHAC Common Stock, par value $0.0001 D 15.000
2018-12-14 3 RICE YEHUDA MICHAEL CHAC Common Stock, par value $0.0001 D 15.000
2018-12-14 3 RICE YEHUDA MICHAEL CHAC Common Stock, par value $0.0001 D 15.000
2018-12-14 3 Chardan Investments, LLC CHAC Common Stock, par value $0.0001 D 3.940.000
2018-12-14 3 Chardan Investments, LLC CHAC Common Stock, par value $0.0001 D 3.940.000
2018-12-14 3 Chardan Investments, LLC CHAC Common Stock, par value $0.0001 D 3.940.000
2018-12-14 3 Giroux Richard CHAC Common Stock, par value $0.0001 D 15.000
2018-12-14 3 Giroux Richard CHAC Common Stock, par value $0.0001 D 15.000
2018-12-14 3 Giroux Richard CHAC Common Stock, par value $0.0001 D 15.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista